Plant Advanced Technologies SA (PA:ALPAT) — Market Cap & Net Worth
Market Cap & Net Worth: Plant Advanced Technologies SA (ALPAT)
Plant Advanced Technologies SA (PA:ALPAT) has a market capitalization of $7.11 Million (€6.08 Million) as of June 21, 2026. Listed on the PA stock exchange, this France-based company holds position #27813 globally and #496 in its home market, demonstrating a -20.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Plant Advanced Technologies SA's stock price €5.40 by its total outstanding shares 1126439 (1.13 Million). Review how much debt does Plant Advanced Technologies SA carry to assess the company's total debt and financial obligations.
Plant Advanced Technologies SA Market Cap History: 2015 to 2026
Plant Advanced Technologies SA's market capitalization history from 2015 to 2026. Data shows change from $34.04 Million to $7.11 Million (-13.90% CAGR).
Plant Advanced Technologies SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Plant Advanced Technologies SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
9.49x
Plant Advanced Technologies SA's market cap is 9.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
18.97x
Plant Advanced Technologies SA's market cap is 18.97 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $24.64 Million | $1.58K | -$1.13K | 15623.21x | N/A |
| 2017 | $32.37 Million | $1.46K | -$674.79 | 22135.02x | N/A |
| 2018 | $21.20 Million | $1.87K | $864.51 | 11323.28x | 24525.46x |
| 2019 | $26.08 Million | $1.17 Million | -$541.23K | 22.23x | N/A |
| 2020 | $27.39 Million | $1.72 Million | -$543.00K | 15.93x | N/A |
| 2021 | $24.49 Million | $2.31 Million | -$1.13 Million | 10.63x | N/A |
| 2022 | $17.52 Million | $2.34 Million | -$849.00K | 7.49x | N/A |
| 2023 | $11.13 Million | $1.68 Million | $79.17K | 6.62x | 140.56x |
| 2024 | $15.67 Million | $1.93 Million | $935.13K | 8.13x | 16.76x |
| 2025 | $10.80 Million | $1.14 Million | $569.40K | 9.49x | 18.97x |
Competitor Companies of ALPAT by Market Capitalization
Companies near Plant Advanced Technologies SA in the global market cap rankings as of June 21, 2026.
Key companies related to Plant Advanced Technologies SA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #445 globally with a market cap of $62.84 Billion USD.
- UCB SA (BR:UCB): Ranked #547 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #571 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $451.63 |
| #445 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.84 Billion | $609.94 |
| #547 | UCB SA | BR:UCB | $49.68 Billion | €249.70 |
| #571 | Argen-X | BR:ARGX | $47.14 Billion | €773.80 |
Plant Advanced Technologies SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Plant Advanced Technologies SA's market cap moved from $34.04 Million to $ 7.11 Million, with a yearly change of -13.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €7.11 Million | -34.15% |
| 2025 | €10.80 Million | -31.09% |
| 2024 | €15.67 Million | +40.83% |
| 2023 | €11.13 Million | -36.47% |
| 2022 | €17.52 Million | -28.49% |
| 2021 | €24.49 Million | -10.58% |
| 2020 | €27.39 Million | +5.05% |
| 2019 | €26.08 Million | +22.98% |
| 2018 | €21.20 Million | -34.50% |
| 2017 | €32.37 Million | +31.37% |
| 2016 | €24.64 Million | -27.62% |
| 2015 | €34.04 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 20th, 2026 the market cap of Plant Advanced Technologies SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.11 Million USD |
| MoneyControl | $7.11 Million USD |
| MarketWatch | $7.11 Million USD |
| marketcap.company | $7.11 Million USD |
| Reuters | $7.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Plant Advanced Technologies SA
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. … Read more